"[Q]uestions have been looming and it's vital that they be addressed."

— Eric Topol, MD, director of the Scripps Translational Science Institute commenting on the need for his group's study to examine the utility of genetic screening for consumer use, particularly since research-grade genome-wide scans have only become feasible since late 2007, "Study aims to assess impact of personal genetic screening"